Skip to content

Yasti Madhu (Glycyrrhiza glabra Linn.) in Mild Cognitive Impairment.

A Randomized open label controlled clinical study to evaluate the efficacy of Yasti Madhu (Glycyrrhiza glabra Linn.) churna with milk in Mild Cognitive Impairment.

Status
Recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/02/062897
Enrollment
30
Registered
2024-02-20
Start date
Unknown
Completion date
Unknown
Last updated
2024-09-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: G319- Degenerative disease of nervous system, unspecified Health Condition 2: G319- Degenerative disease of nervous system, unspecified

Interventions

None listed

Sponsors

Dr Venkatesh S
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: • Subjects aged more than 40 years irrespective of Gender. • Subjects who get score less than 26 in Montreal cognitive assessment scale (MoCA) and less than 24 in Mini mental status (MMSE) scale will be taken for study. • Subjects willing to participate with written informed consent, which is conveyed in the language which the subject can understand.

Exclusion criteria

Exclusion criteria: • Subjects who have lost cognitive function as a result of trauma. • Subjects diagnosed with Tumor, Types of Dementia like Alzheimers dementia, Vascular dementia, Lewy body dementia etc. and lost cognitive function as a result of these. • Subjects under Anti-psychotic drugs, Anti-epileptic drugs will be excluded. • Subjects having any other conditions which can interfere with the treatment will be excluded.

Design outcomes

Primary

MeasureTime frame
Improvement in the Montreal Cognitive Assessment (MOCA) & Mini–Mental State Examination (MMSE) scores.Timepoint: follow up 1: 30thday Follow up 2: 60th day Follow up 3: 90th day Drug free followup : 120th day

Secondary

MeasureTime frame
Improvement in Cognitive behavior (day to day activities) & quality of life.Timepoint: follow up 1: 30thday Follow up 2: 60th day Follow up 3: 90th day Drug free followup : 120th day

Countries

India

Contacts

Public ContactDr Venkatesh S

Sri Sri College of Ayurvedic Science and Research, Bangalore

ayurseema@gmail.com9448330936

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026